Strides Pharma Science Share Price Target For Tomorrow, Next Week & Next Month
Strides Pharma Science Limited | |||
 | Price: ₹819.15 (-0.18%) | ||
| 52 Week Low: ₹513.05 52 Week High: ₹1,675.00 | |||
| Market Capital: 8,018.81 Crore (Midcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Strides Pharma Science Stock Comparison: Strides Pharma Science vs Procter & Gamble Health | Strides Pharma Science vs Wockhardt | Strides Pharma Science vs Sun Pharma Advanced Research Company | Strides Pharma Science vs FDC | Strides Pharma Science vs Vijaya Diagnostic Centre | Strides Pharma Science vs Medplus Health Services | |||
Show Table of Contents
Strides Pharma Science Recent Performance
Over the past 470 trading days, the value of Strides Pharma Science's stock has gained ₹345.20 (+70.86%). On 07 Nov 2023, one share was worth ₹487.15 and by 03 Oct 2025, the value jumped to ₹832.35. During this period it created a highest high of ₹1675.00 and lowest low of ₹472.30.
Strides Pharma Science Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 885 (+8.02%) | Price Action: 10 Sep 2025 High |
| Tomorrow Target 2 | 876 (+6.94%) | Price Action: 16 Sep 2025 Low |
| Tomorrow Target 1 | 867 (+5.84%) | Price Action: 10 Jul 2025 Low |
| Current Price | 819.15 | Strides Pharma Science's share price as of 01 Oct 2025 |
| Stop Loss 1 | 775.47 (-5.34%) | Fibonacci Retracement Level 61.80% |
| Stop Loss 2 | 760.95 (-7.11%) | Price Action: Feb 2025 High |
| Stop Loss 3 | 751.95 (-8.21%) | Price Action: 23 May 2025 High |
Summary
01 Oct 2025: Strides Pharma Science finished the day at ₹819.15, gaining ₹13.20 (+1.61%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -8.20% to 8.04% with:
- Target prices: ₹867 to ₹885
- Support levels: ₹775.47 to ₹751.95
- Recent high: ₹834.80
- Recent low: ₹804.90
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Strides Pharma Science Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 853.98 (+4.25%) | Fibonacci Extension Level 50.00% |
| Next Week Target 2 | 844.62 (+3.1%) | Technical Indicator: MA100 |
| Next Week Target 1 | 835.59 (+2%) | Fibonacci Extension Level 23.60% |
| Current Price | 819.15 | Strides Pharma Science's share price as of 01 Oct 2025 |
| Stop Loss 1 | 813.6 (-0.68%) | Price Action: Oct 2025 Low |
| Stop Loss 2 | 804 (-1.85%) | Price Action: 04 Aug 2025 Low |
| Stop Loss 3 | 794.8 (-2.98%) | Price Action: 29 May 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.97% to 4.25% with:
- Upper targets: ₹835.59 to ₹853.98
- Support levels: ₹813.6 to ₹794.8
Strides Pharma Science Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 898.2 (+9.65%) | Price Action: 22 Jul 2025 High |
| Next Month Target 2 | 889 (+8.52%) | Price Action: 07 Jul 2025 High |
| Next Month Target 1 | 879.8 (+7.4%) | Price Action: 23 Jul 2025 Low |
| Current Price | 819.15 | Strides Pharma Science's share price as of 01 Oct 2025 |
| Stop Loss 1 | 801 (-2.22%) | Price Action: 09 Jun 2025 High |
| Stop Loss 2 | 792.05 (-3.31%) | Price Action: 08 Aug 2025 Low |
| Stop Loss 3 | 783.4 (-4.37%) | Price Action: 03 Jun 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.36% to 9.65% with:
- Target range: ₹879.8 to ₹898.2
- Support levels: ₹801 to ₹783.4
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
